Skip Content
You are currently on the new version of our website. Access the old version .
  • 24 days
    Time to First Decision

Uro, Volume 3, Issue 1

2023 March - 11 articles

Cover Story: The natural history of HPV (Human papilloma virus) infection is well known, but its management is still controversial, especially in men. To decrease the risk of infection and disease progression, the HPV vaccine was first recommended in 2006. Nutraceuticals and phytotherapy compounds have been introduced into the current pharmacopeia for the treatment of HPV infections both in females and males.
Ellagic acid and Annona muricata as phytotherapic compounds seem to demonstrate synergic efficacy in treating HPV infections in terms of viral clearance and HPV-related genital lesions both in male and female patients. In particular, ellagic acid and Annona muricata complexes improve semen quality and HPV-DNA clearance rates in patients with high-risk HPV infection and seem to represent an interesting clinical strategy in terms of increasing the chance of HPV viral clearance in these patients. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (11)

  • Article
  • Open Access
2 Citations
3,272 Views
9 Pages

14 March 2023

Objective: To analyze the role of urodynamic dysfunctions as risk factors for recurrent urinary tract infections (rUTIs) in patients with multiple sclerosis (MS). Material and methods: We conducted a prospective cohort study of 170 patients with MS w...

  • Article
  • Open Access
2,126 Views
8 Pages

2 March 2023

Objectives: to evaluate whether hospitalist co-management would lead to improved outcomes and value in patients undergoing urethroplasty (UPL) with a single surgeon for urethral stricture disease (USD). Material: A co-management model with hospitalis...

  • Review
  • Open Access
2 Citations
12,184 Views
13 Pages

Penile Rehabilitation after Prostate Cancer Treatment: Which Is the Right Program?

  • Roberto Castellucci,
  • Piergustavo De Francesco,
  • Antonio De Palma,
  • Davide Ciavarella,
  • Simone Ferretti,
  • Michele Marchioni and
  • Luigi Schips

23 February 2023

The management of sexual complications after treatment of localized prostate cancer, such as erectile dysfunction, changes in the length of the penis, pain during sexual intercourse, and lack of orgasm, is still an unsolved problem with an important...

  • Review
  • Open Access
4 Citations
5,751 Views
7 Pages

The Role of Ellagic Acid and Annona muricata in the Management of Human Papillomavirus (HPV)-Related Genital Lesions: A Systematic Review

  • Tommaso Cai,
  • Michele Rizzo,
  • Giovanni Liguori,
  • Michele Palumbo,
  • Alessandro Palmieri and
  • Luca Gallelli

5 February 2023

Background: Several reports highlighted the role of nutraceutical compounds in the prevention and management of HPV-related genital lesions both in men and women, with interesting results. Here, we reviewed the effect of ellagic acid and Annona muric...

  • Case Report
  • Open Access
3,214 Views
6 Pages

Ureteral Complications during Surgery

  • Raymond A. Dieter,
  • George B. Kuzycz and
  • William Jacob Dieter

1 February 2023

Historically, ureteral complications during surgery have been occurring since the earliest performances of major abdominal or pelvic surgery. In the early 1960s, few diagnostic techniques were available to diagnose ureteral injury and determine the s...

  • Communication
  • Open Access
1 Citations
5,271 Views
8 Pages

PARP Inhibitors in the Management of BRCA-Positive Prostate Cancer: An Overview

  • Islam Kourampi,
  • Ioannis-Panagiotis Tsetzan,
  • Panagiota Kappi and
  • Nityanand Jain

19 January 2023

Prostate cancer is the second most common form of cancer in men and the fifth leading cause of death among men worldwide. Men with metastatic castration-resistant prostate cancer (mCRPC) often have BRCA-1 or BRCA-2 gene mutations which can make them...

  • Article
  • Open Access
3 Citations
12,744 Views
13 Pages

17 January 2023

Inhibition of 5α-reductase (5αR), which blocks the conversion of testosterone to its active metabolite, dihydrotestosterone, has been shown to impact further prostate enlargement (benign prostatic hyperplasia, or BPH). Clinical trials of...

  • Case Report
  • Open Access
2 Citations
2,442 Views
7 Pages

Traumatic Urinary Bladder and Renal Artery Disruption with Kidney Salvage—A Case Report

  • Raymond A. Dieter,
  • George B. Kuzycz,
  • Robert S. Dieter and
  • Raymond A. Dieter

17 January 2023

Motor vehicle accidents continue to cause thousands of life threatening injuries or mortality (nearly 45,000 deaths in 2021) in the United States. A sixteen year-old young man riding a motorcycle was severely injured when struck by an automobile driv...

  • Feature Paper
  • Article
  • Open Access
2,726 Views
9 Pages

5 January 2023

Background: It is well recognized that patient survival and quality of life are superior with renal transplantation than with dialysis. Organ availability is far outweighed by the large number of wait-listed patients. Additional stratagems are sought...

  • Review
  • Open Access
2 Citations
14,453 Views
9 Pages

Penile Implants: A Lesson from the First 50 Years

  • Alessandro Giordano,
  • Marco Capece,
  • Carlo D’Alterio,
  • Angelo di Giovanni,
  • Assunta Zimarra,
  • Luigi Napolitano,
  • Claudio Marino,
  • Roberto La Rocca,
  • Massimiliano Creta and
  • Alessandro Palmieri
  • + 1 author

27 December 2022

This year marks the fiftieth anniversary of the first implant of an inflatable penile prosthesis (IPP). The authors of this paper want to celebrate the event with a narrative review of the current literature. The main scopes are antibiotic prophylaxi...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Uro - ISSN 2673-4397